Graypoint LLC Illumina, Inc. Transaction History

Graypoint LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$128.91 - $192.44 $4,640 - $6,927	-36 Reduced 1.9%	1,862 $255,000
Q2 2023 Jul 21, 2023	SELL	$183.43 - $232.67 $24,396 - $30,945	-133 Reduced 6.55%	1,898 $355,000
Q1 2023 May 02, 2023	BUY	$193.75 - $232.55 $68,975 - $82,787	356 Added 21.25%	2,031 $472,000
Q4 2022 Jan 31, 2023	BUY	$187.24 - $242.74 $114,029 - $147,828	609 Added 57.13%	1,675 $338,000
Q3 2022 Oct 31, 2022	BUY	$177.23 - $227.44 $188,927 - $242,451	1,066 New	1,066 $203,000
Q2 2022 Aug 01, 2022	SELL	$181.58 - $368.0 $149,258 - $302,496	-822 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$303.87 - $423.8 $10,635 - $14,833	35 Added 4.45%	822 $287,000
Q4 2021 Jan 31, 2022	BUY	$347.28 - $421.83 $77,443 - $94,068	223 Added 39.54%	787 $299,000
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $228,764 - $296,009	564 New	564 $229,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

Stay updated on Graypoint LLC with notifications on news.